News
Teleflex Announces European Market Clearance for its Arrow® GPSCath® Balloon Dilatation Catheter
May 29, 2013 7:30 am | by Business Wire | CommentsTeleflex Incorporated (NYSE: TFX), a leading global provider of medical devices for critical care and surgery, has announced that its subsidiary Hotspur Technologies, Inc., which Teleflex acquired in June 2012, completed CE marking requirements to market the company’s Arrow ® GPSCath ® Balloon Dilatation Catheters to the European Union.
ZELTIQ Aesthetics Wins Two Major Legal Decisions
May 28, 2013 12:45 pm | by Globe Newswire | CommentsZELTIQ® Aesthetics, Inc. (Nasdaq:ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, today announced that it prevailed in two major legal cases.
Covidien Nellcor Pulse Oximeters Receive FDA 510(k) Clearance with Labeling for Use in Newborn Screening for Critical Congenital Heart Disease
May 28, 2013 12:35 pm | by Covidien | CommentsCovidien’s new CCHD labeling was introduced as part of the FDA 510(k)-cleared labeling for motion tolerant Nellcor pulse oximeters. In 2011, the U.S. Department of Health and Human Services added CCHD screening to the Federal Recommended Uniform Screening Panel Guidelines.
PA Girl's Parents Challenge Lung Donor Rule
May 28, 2013 12:30 pm | by Ron Todt, Associated Press | CommentsThe parents of a 10-year-old Pennsylvania girl who has been waiting for a lung transplant for a year and a half are calling for a change in the policy governing organ transplants that they say has prevented their increasingly sick daughter from getting life-saving surgery.
FDA Approves Blood Test to Diagnose Diabetes
May 28, 2013 10:56 am | by The Associated Press | CommentsThe Food and Drug Administration said Thursday it approved a new blood test from Roche to help doctors diagnose diabetes. The Cobas Integra 800 is a blood test that measures a patient's average blood sugar level over the previous three months. In particular, the test measures an oxygen-carrying blood component known as hemoglobin.
Mom's Obesity Surgery May Help Break Cycle in Kids
May 28, 2013 10:54 am | by Lauran Neergaard, AP Medical Writer | CommentsObese mothers tend to have kids who become obese. Now provocative research suggests weight-loss surgery may help break that unhealthy cycle in an unexpected way — by affecting how their children's genes behave. In a first-of-a-kind study, Canadian researchers tested children born to obese women, plus their brothers and sisters who were conceived after the mother had obesity surgery.
Valeant to Buy Bausch + Lomb for $8.7B
May 28, 2013 10:29 am | by Linda A. Johnson, AP Business Writer | CommentsCanadian drugmaker Valeant Pharmaceuticals has agreed to pay $8.7 billion to buy Bausch + Lomb, one of the world's best-known makers of contact lenses, in a massive expansion of Valeant's smaller ophthalmology business. Valeant said Monday that the cash deal will help it capitalize on increasing demand for contact lenses and other products because of aging populations, growing demand in emerging markets and increasing rates of diabetes.
Sports Seem OK for Many with Heart-Zapping Device
May 28, 2013 10:18 am | by Lauran Neergaard, AP Medical Writer | CommentsNew research is challenging medical guidelines that say people with a heart-zapping device in their chests should avoid intense sports like basketball and soccer in favor of golf or bowling. Lots of patients ignore that take-it-easy advice and stay in the game, and Monday's findings suggest vigorous exercise may be safe for many of them after all.
Full Spectrum Endoscopy Procedure Reduces 'Miss Rate'
May 28, 2013 10:16 am | by EndoChoice | CommentsAlthough colonoscopy exams prevent many colon cancer deathsand are considered the most sensitive method for detecting colorectal cancers, the procedure is not completely effective in preventing cancer cases. EndoChoice has unveiled research that shows that its new Fuse system significantly improves the accuracy of this procedure and greatly reduces the number of adenomas missed by colonoscopists.
Imaging Technology for Joint Replacements and Implanted Devices
May 28, 2013 10:13 am | by GE Healthcare | CommentsGE Healthcare (NYSE: GE) has introduced MAVRIC SL, a novel magnetic resonance (MR) imaging technique designed to address the growing clinical need to more accurately image soft tissue and bone in patients with MR Conditional-labeled implants, such as joint replacements and other instrumentation.
Spine Function Improves Following Cell Replacement Therapy with Fetal Human Stem Cells
May 28, 2013 10:06 am | by BioMed Central | CommentsHuman fetal stem cell grafts improve both motor and sensory functions in rats suffering from a spinal cord injury, according to research published this week in BioMed Central's open access journal Stem Cell Research and Therapy. This cell replacement therapy also improves the structural integrity of the spine, providing a functional relay through the injury site.
High-Tech Industry Big Immigration Bill Winner
May 28, 2013 10:04 am | by Erica Werner, Associated Press | CommentsMore than any other group, the high-tech industry got big wins in an immigration bill approved by the Senate Judiciary Committee last week, thanks to a concerted lobbying effort, an ideally positioned Senate ally and relatively weak opposition. The result amounted to a bonanza for the industry.
Heli-FX™ Guide Designed to Treat Wide Neck Abdominal Aortic Aneurysms Receives FDA Clearance
May 28, 2013 8:15 am | by Business Wire | CommentsAptus Endosystems, Inc. announced today that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its 28mm Tip Reach Heli-FX™ Guide. A line extension of the original Heli-FX System, the new product enhances treatment of wide neck abdominal aortic aneurysms (AAA).
OrSense Non Invasive Hemoglobin Monitor Shown Safe and Accurate for Pre-Donation Screening in Blood Banks
May 28, 2013 7:00 am | by Business Wire | CommentsOrSense Ltd., developer of monitors for non-invasive measurements of various blood parameters, announced today that its non-invasive Hemoglobin (Hb) NBM-200 monitor was the topic of multiple recent studies highlighting the clinical value of the device.
Boston Scientific Receives CE Mark Approval For GUIDE™ DBS System
May 27, 2013 5:15 pm | by PR Newswire | CommentsBoston Scientific Corporation has received CE Mark approval for use of the GUIDE™ DBS System, the world's first deep brain stimulation (DBS) visualization system. GUIDE DBS provides clinicians with 3D visualization information that simulates stimulation output, which may reduce programming time and enable more precise targeting of therapy.
